Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Active Not Recruiting Phase 1 Trials for Onalespib (DB06306)

IndicationStatusPhase
DBCOND0088319 (Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02381535Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and CisplatinTreatment